Neuroinflammation and autism: what have we learned so far?

Area of Science:

• Neuroscience
• Immunology
• Genetics

Background:

• Autism spectrum disorder (ASD) is a neurodevelopmental disorder with rising prevalence and unclear etiology.
• Growing evidence suggests a potential role for inflammatory changes and autoimmune conditions in ASD pathogenesis.
• Immune molecules like cytokines and chemokines may influence synapse development and cortical connectivity in ASD.

Purpose of the Study:

• To review clinical and preclinical data on the autism-inflammation relationship.
• To summarize hypotheses linking autism and inflammation.
• To explore potential therapeutic targets for neuroinflammation in ASD.

Main Methods:

• Literature review of clinical and preclinical studies.
• Analysis of research on immune system molecules (cytokines, chemokines) in ASD.
• Examination of studies on potential treatments like exosomes, mTOR pathway modulation, probiotics, luteolin, and minocycline.

Main Results:

• Inflammatory changes and autoimmune links are observed in individuals with ASD.
• Immune molecules potentially impact neural development in ASD.
• Investigational treatments (exosomes, mTOR modulators, probiotics, etc.) show promise but require more evidence.
• Existing data on autism and inflammation is extensive but often contradictory.

Conclusions:

• Neuroinflammation is a significant area of research for understanding ASD.
• While promising, current evidence for specific anti-inflammatory treatments in ASD is limited.
• Further research is crucial to clarify the complex relationship between autism and inflammation and develop effective therapies.